Accelerated Epigenetic Aging Correlates with Later Loss of Memory Function
Key claim: Accelerated epigenetic aging measured by DNA methylation clocks correlates with later loss of memory function, though aging clocks still lack a clear mechanistic basis for therapy assessment.
Abstract
Aging clocks have yet to fulfill their promise, which is to produce a robust measure of biological aging that can be used to rapidly assess the results of potential therapies to slow or reverse the progression of aging, such as via repair of underlying cell and tissue damage that causes aging. This is because these clocks are produced by machine learning approaches applied to data from a patient population, such as omics data, that changes with age. Exactly why any specific combinations of measures identified in this way, such as the state of DNA methylation at scores of specific CpG sites on the nuclear genome in the case of epigenetic clocks, can predict age or mortality risk is a mystery. There is no way at […]
Why this matters
Accelerated epigenetic aging measured by DNA methylation clocks correlates with later loss of memory function, though aging clocks still lack a clear mechanistic basis for therapy assessment.